Map the system. Preserve the evidence. Test the handoff.
Source-backed reporting and analysis connected to the companies, capabilities, authorities, and operating domains it affects.
CDD Vault presents activity-data management, standardized assay context, curve fitting, visualization, and entity registration. A fitted curve still needs traceable samples, protocol, concentrations, units, run controls, model choices, exclusions, uncertainty, and a separately reviewed comparison before it can inform compound ranking.
POMS documents equipment management within its POMSnet Aquila pharmaceutical manufacturing-execution system. A displayed equipment status can support manufacturing execution, but analytical-instrument readiness still depends on the correct instrument identity, qualification, calibration, maintenance, method, software, access, system-suitability, exception, and laboratory approval records.
Uncountable says its Bodie assistant can edit tables, create records, and update fields. State-changing actions need identity, scope, source, preview, approval, version, validation, and reversal controls.
Scitara documents a laboratory integration platform for connecting instruments, applications, services, and workflows. A successful connector event can show that a transfer step ran, but it cannot prove that every raw file, metadata element, relationship, checksum, and exception arrived intact in the intended system of record.
Agilent documents OpenLab CDS for chromatography data acquisition, processing, reporting, and controlled review workflows. Technical controls can preserve signatures, permissions, versions, and audit history, but the laboratory still has to show that a qualified reviewer examined the right evidence and made a defensible decision.
Dotmatics presents an electronic lab notebook that can organize experimental records and support AI-assisted write-ups and analysis. Generated text can accelerate review, but it cannot establish that the source data, method, interpretation, attribution, or scientific conclusion is correct.
NIH requires applicable researchers to plan for managing and sharing scientific data and to comply with approved plans. The policy creates an evidence obligation, not a universal repository decision or proof that an ELN alone satisfies the plan.
FDA's CGMP records guidance says a paper chromatogram generally omits the injection sequence, instrument method, integration method, and audit trail associated with the result. A printable report can support review, but it cannot silently replace the retained electronic source record.
Waters documents NuGenesis as a laboratory-management platform that combines SDMS, electronic laboratory notebook, sample, stability, search, retention, and execution workflows. Those connected functions do not make it the chromatography data system that controls acquisition, processing, methods, results, and instrument-specific audit evidence.
OECD Advisory Document No. 22 asks GLP facilities to understand data flows, risk, criticality, and lifecycle. A reviewed final value cannot prove that the underlying dynamic data, metadata, processing, transfer, and archive remain reconstructable.
Version 2.0 broadens the buyer test from notebook authoring or file retention to planning, generation, processing, analysis, sharing, preservation, reuse, governance, infrastructure, standards, workforce, and community.
The emerging ASTM XML standard can structure analytical records across systems without proving that a conversion, method, or result is valid.
